Rapdidus will start producing 2-nanometer chips in April next year. Dong Zhelang, president of Rapdidus, an advanced Japanese semiconductor foundry company, said that by the end of March 2025, Rapdidus will complete all the equipment setup required for trial production of 2-nanometer chips, and start the trial production line in April to actually produce 2-nanometer chips.Lingang Daya Auto Parts Intelligent Manufacturing Base Project officially started. On the morning of December 12th, the groundbreaking ceremony of Lingang Daya Auto Parts Intelligent Manufacturing Base Project was held in Shanghai Lingang Fengxian Park. After the completion of the project, two 3500T/2500T high-speed multi-position stamping lines are designed, with an annual production capacity of 11 million pieces; Design 210 connection workstations such as spot welding/arc welding/projection welding/riveting, with an annual production capacity of 4 million sets of sheet metal parts; Design an intelligent logistics and three-dimensional warehouse.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)
The Syrian Sharm el-Liberation Organization said that it would disband the Syrian government security forces. On December 11th, Giulani, leader of the Syrian Sharm el-Liberation Organization, said in a statement to Reuters that he would disband the Syrian government security forces and close the prison.Israeli: Community alarm sounded near Gaza.The OpenAI webpage shows that API, ChatGPT and Sora are all running normally.
Huaxin Securities: China Unicom's operating income grew steadily and maintained its "buy" rating. Huaxin Securities Research Report pointed out that since the beginning of this year, China Unicom (600050.SH) has seen steady growth in operating income, rapid improvement in profitability, steady expansion of user scale and continuous consolidation of network foundation, laying a more solid foundation for high-quality development of enterprises. Communication and digital intelligence services are driven by two wheels, injecting vitality into the company's performance. Looking forward to the whole year, the company will adhere to the general tone of steady progress, promote the network to be new, technology to be new and service to be new, strive to achieve the performance goal of steady growth of operating income and double-digit growth of profits throughout the year, take greater steps in high-quality development, and accelerate the construction of a world-class science and technology service enterprise with global competitiveness. With the gradual expansion of user scale and the drive of digital transformation, the company will benefit from the continuous improvement of revenue and profit and maintain the "buy" investment rating.Mengke Pharmaceutical Co., Ltd.: The new packaging of Contizontamide tablets will be on the market soon. Mengke Pharmaceutical Co., Ltd. announced that the company has launched Contizontamide tablets with new packaging specifications, and a box of 12 tablets will be on the market soon. Contizontamide tablet is a new class 1 oxazolidinone antibacterial drug with global intellectual property rights. It was approved by National Medical Products Administration, China on June 1st, 2021 for the treatment of complex skin and soft tissue infections.U.S. and cloth oil fell 0.3 USD in short term, and now they are reported at 70.08 USD/barrel and 73.50 USD/barrel respectively.
Strategy guide
12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide